Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Hsin Chen

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|August 1, 2022
Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the ProstateYung-Ting Cheng, Jian-Hua Hong, Yu-Chuan Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Aristolochic acid-associated urothelial cancer in TaiwanChung-Hsin Chen, Kathleen G Dickman, Masaaki Moriya, et al.
American Journal of Cancer Research|August 15, 2022
LMNB1, a potential marker for early prostate cancer progressionJian-Hua Hong, Sung-Tzu Liang, Alexander Sheng-Shin Wang, et al.
The World Journal of Men'S Health|October 19, 2023
Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive FactorsJian-Hua Hong, Ming-Chieh Kuo, Yung-Ting Cheng, et al.
Biomedicines|October 26, 2024
Prognostic Outcomes and Predictive Factors in Non-Metastatic Castration-Resistant Prostate Cancer Patients Not Treated with Second-Generation AntiandrogensYu-Jen Wang, Chi-Shin Tseng, Chao-Yuan Huang, et al.
World Journal of Urology|December 13, 2018
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral centerChi-Shin Tseng, Ting-En Tai, Chung-Hung Hong, et al.
Liver Cancer|December 15, 2025
Aristolochic Acid and Alternative Lengthening of Telomeres Mechanisms Underlie Liver Angiosarcoma PathogenesisTom Wei-Wu Chen, Chiun Hsu, Jen-Chieh Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 25, 2016
Aristolochic Acid in the Etiology of Renal Cell CarcinomaMargaret L Hoang, Chung-Hsin Chen, Pau-Chung Chen, et al.
World Journal of Surgical Oncology|November 8, 2015
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancerYu-Jen Wang, Chao-Yuan Huang, Wei-Hsien Hou, et al.
Molecular Oncology|March 17, 2023
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomyYu-Chuan Lu, Chen-Hsun Ho, Jian-Hua Hong, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|August 1, 2022
Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the ProstateYung-Ting Cheng, Jian-Hua Hong, Yu-Chuan Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Aristolochic acid-associated urothelial cancer in TaiwanChung-Hsin Chen, Kathleen G Dickman, Masaaki Moriya, et al.
American Journal of Cancer Research|August 15, 2022
LMNB1, a potential marker for early prostate cancer progressionJian-Hua Hong, Sung-Tzu Liang, Alexander Sheng-Shin Wang, et al.
The World Journal of Men'S Health|October 19, 2023
Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive FactorsJian-Hua Hong, Ming-Chieh Kuo, Yung-Ting Cheng, et al.
Biomedicines|October 26, 2024
Prognostic Outcomes and Predictive Factors in Non-Metastatic Castration-Resistant Prostate Cancer Patients Not Treated with Second-Generation AntiandrogensYu-Jen Wang, Chi-Shin Tseng, Chao-Yuan Huang, et al.
World Journal of Urology|December 13, 2018
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral centerChi-Shin Tseng, Ting-En Tai, Chung-Hung Hong, et al.
Liver Cancer|December 15, 2025
Aristolochic Acid and Alternative Lengthening of Telomeres Mechanisms Underlie Liver Angiosarcoma PathogenesisTom Wei-Wu Chen, Chiun Hsu, Jen-Chieh Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 25, 2016
Aristolochic Acid in the Etiology of Renal Cell CarcinomaMargaret L Hoang, Chung-Hsin Chen, Pau-Chung Chen, et al.
World Journal of Surgical Oncology|November 8, 2015
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancerYu-Jen Wang, Chao-Yuan Huang, Wei-Hsien Hou, et al.
Molecular Oncology|March 17, 2023
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomyYu-Chuan Lu, Chen-Hsun Ho, Jian-Hua Hong, et al.
Pageof 9